
Olmibid Trio 20mg/5mg/12.5mg Tablet
Marketer
Eswar Therapeutics Pvt Ltd
Salt Composition
Olmesartan Medoxomil (20mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Olmibid Trio 20mg/5mg/12.5mg Tablet
Hypertrio, a 20mg/5mg/12.5mg combination tablet, manages hypertension when monotherapy proves insufficient. By lowering elevated blood pressure, it significantly reduces the risk of stroke and myocardial infarction. Hypertrio can be administered with or without food, dosage tailored to individual response and condition. Consistent daily timing is recommended. Continuous use, as directed by your physician, is crucial; discontinuation increases stroke and heart attack risk. Containing a diuretic, increased urination is expected, so avoid late-evening dosing (within four hours of sleep). Regular intake maximizes therapeutic benefit, even during asymptomatic periods. Common side effects may include edema (ankle swelling), cephalgia (headache), vertigo (dizziness), fatigue, and altered taste perception. Report persistent, worsening, or bothersome side effects to your doctor. Hydration is important to mitigate potential side effects like muscle weakness, xerostomia (dry mouth), and polydipsia (extreme thirst). Prior to initiating therapy, disclose any renal or hepatic impairment to your physician. Pregnant or lactating individuals require prior medical consultation. Comprehensive disclosure of all medications, especially those for hypertension or cardiac conditions, is essential. Regular monitoring of blood pressure, renal function, electrolyte levels, and glycemia ensures optimal therapeutic response.
Primary Ingredients of Olmibid Trio 20mg/5mg/12.5mg Tablet
No text provided. Please provide the text you wish me to rephrase.
Uses of Olmibid Trio 20mg/5mg/12.5mg Tablet
Elevated blood pressure
Major Benefits of Olmibid Trio 20mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Olmibid Trio 20mg/5mg/12.5mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. These tablets can be administered with or without food, however, consistent daily timing is recommended.
Common Side effects of Olmibid Trio 20mg/5mg/12.5mg Tablet:
- Headache
- Dizziness
- Nausea
- Upper respiratory tract infection
- Fatigue
- Urinary tract infection
- Diarrhea
- Joint swelling
- Peripheral edema
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Muscle spasm
- Hypotension (low blood pressure)
- Increased creatinine level in blood
- Increased blood urea
- Increased uric acid level in blood
How to use Olmibid Trio 20mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Olmibid Trio 20mg/5mg/12.5mg tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be independent of food, however, consistent timing is recommended.
How Olmibid Trio 20mg/5mg/12.5mg Tablet works:
The fixed-dose combination tablet, Olmibid Trio 20mg/5mg/12.5mg, contains olmesartan medoxomil, amlodipine, and hydrochlorothiazide. Olmesartan medoxomil, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, both act to dilate blood vessels, reducing blood pressure. Hydrochlorothiazide, a diuretic, facilitates the excretion of excess fluid and electrolytes, contributing to lower blood pressure through improved vascular tone and blood flow.
SAFETY ADVICE
AlcoholUNSAFE
Combining Olmibid Trio 20mg/5mg/12.5mg tablets with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
Use of Olmibid Trio 20mg/5mg/12.5mg tablets is contraindicated during pregnancy due to confirmed risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The use of Olmibid Trio 20mg/5mg/12.5mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Olmibid Trio 20mg/5mg/12.5mg Tablets, due to potential side effects including dizziness, headaches, nausea, or fatigue. These side effects can reduce concentration and impact safe driving.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Olmibid Trio 20mg/5mg/12.5mg tablets, as dosage modification may be necessary. A physician's consultation is advised. Olmibid Trio 20mg/5mg/12.5mg tablets are not recommended for individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Olmibid Trio 20mg/5mg/12.5mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Olmibid Trio 20mg/5mg/12.5mg Tablet :
Should you forget to take your Olmibid Trio 20mg/5mg/12.5mg Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olmibid Trio 20mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |
